Synovus Financial’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $982K | Sell |
3,634
-3,296
| -48% | -$897K | 0.01% | 525 |
|
|
2025
Q2 | $1.91M | Sell |
6,930
-145
| -2% | -$39.4K | 0.02% | 360 |
|
|
2025
Q1 | $1.88M | Buy |
7,075
+442
| +7% | +$109K | 0.02% | 360 |
|
|
2024
Q4 | $1.54M | Sell |
6,633
-480
| -7% | -$110K | 0.02% | 395 |
|
|
2024
Q3 | $1.57M | Sell |
7,113
-647
| -8% | -$134K | 0.02% | 408 |
|
|
2024
Q2 | $1.53M | Buy |
7,760
+3,701
| +91% | +$765K | 0.02% | 370 |
|
|
2024
Q1 | $874K | Buy |
4,059
+12
| +0.3% | +$2.52K | 0.01% | 486 |
|
|
2023
Q4 | $852K | Sell |
4,047
-5,851
| -59% | -$1.25M | 0.01% | 462 |
|
|
2023
Q3 | $1.98M | Sell |
9,898
-3,727
| -27% | -$741K | 0.02% | 338 |
|
|
2023
Q2 | $2.52M | Sell |
13,625
-1,214
| -8% | -$224K | 0.03% | 309 |
|
|
2023
Q1 | $2.84M | Sell |
14,839
-1,005
| -6% | -$182K | 0.03% | 281 |
|
|
2022
Q4 | $2.66M | Buy |
15,844
+61
| +0.4% | +$10.6K | 0.03% | 292 |
|
|
2022
Q3 | $2.8M | Sell |
15,783
-228
| -1% | -$45.1K | 0.03% | 259 |
|
|
2022
Q2 | $3.27M | Buy |
16,011
+2,655
| +20% | +$563K | 0.04% | 228 |
|
|
2022
Q1 | $3.18M | Sell |
13,356
-2,146
| -14% | -$504K | 0.03% | 252 |
|
|
2021
Q4 | $3.54M | Sell |
15,502
-11,380
| -42% | -$2.5M | 0.04% | 243 |
|
|
2021
Q3 | $5.2M | Buy |
26,882
+7,001
| +35% | +$1.42M | 0.06% | 182 |
|
|
2021
Q2 | $4.23M | Sell |
19,881
-390
| -2% | -$82.3K | 0.04% | 201 |
|
|
2021
Q1 | $4.12M | Sell |
20,271
-1,632
| -7% | -$321K | 0.05% | 189 |
|
|
2020
Q4 | $4M | Buy |
21,903
+630
| +3% | +$107K | 0.05% | 192 |
|
|
2020
Q3 | $3.57M | Sell |
21,273
-5,161
| -20% | -$869K | 0.05% | 186 |
|
|
2020
Q2 | $4.3M | Buy |
26,434
+282
| +1% | +$50.5K | 0.06% | 150 |
|
|
2020
Q1 | $4.53M | Buy |
26,152
+4,991
| +24% | +$993K | 0.06% | 157 |
|
|
2019
Q4 | $4.24M | Buy |
21,161
+547
| +3% | +$112K | 0.06% | 156 |
|
|
2019
Q3 | $4.36M | Sell |
20,614
-658
| -3% | -$137K | 0.07% | 144 |
|
|
2019
Q2 | $4.14M | Sell |
21,272
-8,074
| -28% | -$1.49M | 0.06% | 147 |
|
|
2019
Q1 | $4.82M | Buy |
29,346
+3,269
| +13% | +$578K | 0.08% | 137 |
|
|
2018
Q4 | $4.91M | Buy |
26,077
+285
| +1% | +$52.6K | 0.09% | 127 |
|
|
2018
Q3 | $4.39M | Buy |
25,792
+6,231
| +32% | +$1.05M | 0.07% | 148 |
|
|
2018
Q2 | $3.21M | Buy |
19,561
+4,860
| +33% | +$794K | 0.05% | 170 |
|
|
2018
Q1 | $2.38M | Buy |
14,701
+1,080
| +8% | +$172K | 0.04% | 205 |
|
|
2017
Q4 | $1.99M | Buy |
+13,621
| New | +$1.94M | 0.03% | 213 |
|
|
2017
Q3 | – | Sell |
-3,349
| Closed | -$420K | – | 586 |
|
|
2017
Q2 | $420K | Sell |
3,349
-1,165
| -26% | -$139K | 0.01% | 444 |
|
|
2017
Q1 | $535K | Buy |
4,514
+1,321
| +41% | +$159K | 0.01% | 347 |
|
|
2016
Q4 | $367K | Sell |
3,193
-134
| -4% | -$14.9K | 0.01% | 387 |
|
|
2016
Q3 | $346K | Buy |
3,327
+357
| +12% | +$37.3K | 0.01% | 397 |
|
|
2016
Q2 | $292K | Buy |
2,970
+63
| +2% | +$5.95K | 0.01% | 412 |
|
|
2016
Q1 | $279K | Buy |
2,907
+2,704
| +1,332% | +$246K | 0.01% | 419 |
|
|
2015
Q4 | $18K | Buy |
203
+100
| +97% | +$9.41K | ﹤0.01% | 776 |
|
|
2015
Q3 | $9K | Hold |
103
| – | – | ﹤0.01% | 828 |
|
|
2015
Q2 | $9K | Hold |
103
| – | – | ﹤0.01% | 844 |
|
|
2015
Q1 | $9K | Buy |
103
+68
| +194% | +$6.3K | ﹤0.01% | 879 |
|
|
2014
Q4 | $3K | Hold |
35
| – | – | ﹤0.01% | 968 |
|
|
2014
Q3 | $3K | Sell |
35
-84
| -71% | -$6.33K | ﹤0.01% | 922 |
|
|
2014
Q2 | $8K | Hold |
119
| – | – | ﹤0.01% | 825 |
|
|
2014
Q1 | $9K | Buy |
119
+49
| +70% | +$3.7K | ﹤0.01% | 816 |
|
|
2013
Q4 | $5K | Hold |
70
| – | – | ﹤0.01% | 820 |
|
|
2013
Q3 | $5K | Buy |
+70
| New | +$5.16K | ﹤0.01% | 796 |
|
Other funds holding CME
Synovus Financial's CME Position: Q3 2025 in Review
Synovus Financial reduced its CME Group (CME) stake by 48% in Q3 2025, selling an estimated $897K and leaving 3,634 shares worth $982K. The position accounts for 0.01% of the portfolio, ranked #525.
Synovus Financial first reported a position in CME in Q3 2013 and has held it in 48 quarters since. The position peaked at $5.2M in Q3 2021. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.
- Synovus Financial held 3,634 shares of CME Group worth $982K as of Q3 2025.
- Synovus Financial sold 3,296 CME Group shares in Q3 2025, an estimated $897K.
- CME Group made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #525 holding.
- Synovus Financial first reported a position in CME Group in Q3 2013 and has held it in 48 quarters since.
- Synovus Financial's CME Group position peaked at $5.2M in Q3 2021.
- 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.